Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Kavita Mane

80 indexed publications match this author name.

ORCID
Not found in stored metadata
OpenAlex
Not found in stored metadata

Author watchlist

Create a confirmed email alert for new publications matching this author.

Publication history

Quantifying psilocybin exposure in a natural product-based retreat setting: An observational field method for dose measurementPsychedelics · 2026-12-01Which Psychedelic Therapy Should Rural Health Systems Pursue First: Psilocybin or Ibogaine?The Permanente Journal · 2026-11-05Safety and efficacy of psilocybin-assisted therapy for alcohol use disorder: Open-label extension of a phase II randomized controlled trialDrug and Alcohol Dependence · 2026-11-01Cost-Effectiveness of Psilocybin-Assisted Therapy Versus Standard of Care for Patients With Treatment-Resistant DepressionValue in Health Regional Issues · 2026-11-01Prevalence and Correlates of Past-Year Psilocybin Use in the United StatesAmerican Journal of Psychiatry · 2026-11-01Substantial Treatment-Seeking Interest, Narrow Eligibility: Diagnostic Heterogeneity and External Validity in the PRIDE Psilocybin Trial-Relevance to Precision PsychiatryBehavioral Sciences · 2026-10-26Sex-related differences in outcomes following psilocybin or escitalopram: a Bayesian secondary analysis.Psychopharmacology · 2026-10-26Clinical Evidence on Psilocybin and Its Representation in Media ReportingJAMA Network Open · 2026-10-20Psilocybin in Treatment-Resistant Depression: Weighing Rapid Antidepressant Effects Against Uncertain DurabilityTherapeutics · 2026-10-19Coding and Classification Errors in Study of Psilocybin ServicesJAMA Network Open · 2026-10-16Cannabis and Psilocybin Co-use: Associations with Stress and Well-beingInternational Journal of Mental Health and Addiction · 2026-10-13Efficacy and safety of psilocybin-assisted therapy for alcohol use disorder: A systematic review and meta-analysisJournal of Psychopharmacology · 2026-10-08PsilocybinJAMA · 2026-10-06Placebo, Psilocybin und der vermaledeite p-WertNervenheilkunde · 2026-10-01Prevalence and Reasons for Microdosing Cannabis, Psilocybin, LSD, and MDMA Among U.S. AdultsAmerican Journal of Preventive Medicine · 2026-10-01Adverse Health Outcomes of Psilocybin, LSD, MDMA, Ibogaine, and 5-MeO-DMTJAMA Network Open · 2026-09-29Level of preparedness to use psilocybin among individuals seeking psychedelic risk reduction: a retrospective study of a pilot psychiatric consultation serviceFrontiers in Public Health · 2026-09-16The subtle science: a systematic review of psilocybin magic mushroom and truffle microdosingFrontiers in Psychiatry · 2026-08-19Safety and Mental Health Outcomes of Oregon State-Regulated Psilocybin ServicesJAMA Network Open · 2026-08-19Psilocybin for Fear of Cancer RecurrenceSupportive Care in Cancer · 2026-08-01Cardiovascular safety of psilocybin in psychiatric practice: a narrative reviewEuropean Journal of Clinical Pharmacology · 2026-08-01The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysisJournal of Affective Disorders · 2026-08-01Safety, feasibility, and preliminary clinical outcomes of psilocybin-assisted therapy for veterans with severe, treatment-resistant PTSD: an open-label pilot clinical trialCommunications Medicine · 2026-07-30Reporting practices in psilocybin-assisted therapy trials for depression: A descriptive review and temporal overviewJournal of Psychedelic Studies · 2026-07-13Psilocybin therapy for adult females with anorexia nervosa: pilot studyThe British Journal of Psychiatry · 2026-07-08Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical DevelopmentBiomolecules · 2026-07-03Trajectories of psychedelic-assisted change: An observational study of a psilocybin retreat program followed by psychotherapeutic interventionsJournal of Psychedelic Studies · 2026-07-03Acceptability and safety of two sequential doses of psilocybin in bipolar II depression: protocol for an open-label single-arm feasibility studyBMJ Open · 2026-07-01Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic CircuitsHuman Brain Mapping · 2026-07-01Implementing psilocybin-assisted therapy in palliative care settings: A survey of stakeholdersPalliative Medicine · 2026-07-01Psilocybin reduces fear memory and restores neuroplasticity in the hippocampus and medial prefrontal cortexJournal of Psychopharmacology · 2026-06-28PSILOCYBIN IN THE TREATMENT OF DEPRESSIVE DISORDERS: CLINICAL EVIDENCE AND ITS POTENTIAL TO ADDRESS THE GLOBAL MENTAL HEALTH CRISIS - A REVIEWInternational Journal of Innovative Technologies in Social Science · 2026-06-24Psilocybin and Mental Health Outcomes: Scoping Review with ☸️SAIMSARASAIMSARA Journal · 2026-06-15Prenatal stress, excitatory-inhibitory imbalance, and ADHD risk: a hypothesis-driven perspective on psilocybin-induced neuroplasticityTranslational Psychiatry · 2026-06-05Developing Methods for Observing Awe Narration in Psilocybin-Assisted TherapyHealthcare · 2026-06-05Psilocybin: Chemical Foundations and Emerging Therapeutic PotentialMini-Reviews in Medicinal Chemistry · 2026-06-01Effect of psilocybin-assisted psychotherapy on anxiety symptoms: A systematic review and meta-analysisJournal of Psychedelic Studies · 2026-05-29Psilocybin-induced neurocardiogenic syncope: a case reportPsychopharmacology · 2026-05-28Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major DepressionJAMA Network Open · 2026-05-15Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of CareCurrent Psychiatry Reports · 2026-05-14Neural correlates of insight on psilocybin: a within-subjects, healthy volunteer studyJoCN Forum · 2026-05-08Psilocybin in the Treatment of Cocaine Use DisorderJAMA Network Open · 2026-05-07Pilot Results for Psilocybin-Assisted Psychotherapy for Cocaine Use Disorder-A Critical AppraisalJAMA Network Open · 2026-05-07The magic of mushrooms: psilocybin influences behavior in the mangrove rivulus fish, Kryptolebias marmoratusFrontiers in Behavioral Neuroscience · 2026-05-07Human brain changes after first psilocybin useNature Communications · 2026-05-05Advancing cancer neuroscience through stress modulation: Interdisciplinary potential of psilocybin and ketamineGeneral Hospital Psychiatry · 2026-05-01Efficacy and Safety of Psilocybin in Treatment-Resistant Major DepressionJAMA Psychiatry · 2026-05-01Psilocybin use among Basotho healers and non-healers in southern AfricaOSF Preprints · 2026-04-23The efficacy and safety of psilocybin-assisted therapy for major depressive disorder: a meta-analytic review of clinical outcomesMental Wellness · 2026-04-21Observing the mind under psychedelics: conceptual metaphors used following four once-weekly macrodoses of psilocybinPhilosophical Psychology · 2026-04-10A living systematic review, meta-analysis and open-data resource of randomized controlled trials of psilocybin treatment for symptoms of depressionNature Mental Health · 2026-04-06Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical ImplicationsFocus · 2026-04-01Consistency of protocol and safety data reporting in clinical trial registrations and corresponding publications of interventions involving MDMA and psilocybinJournal of Clinical Epidemiology · 2026-04-01Regulatory ambiguity and governance challenges for psilocybin mushrooms in BrazilInternational Journal of Drug Policy · 2026-04-01An international mega-analysis of psychedelic drug effects on brain circuit function.Nature medicine · 2026-04-01Psilocybin retail stores in Canada: Changes in availability, commercialization, and geographic distributionCanadian Journal of Public Health · 2026-03-19Psilocybin or Nicotine Patch for Smoking CessationJAMA Network Open · 2026-03-10Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapyJournal of Affective Disorders · 2026-03-01Pilot study of psilocybin in patients with post-treatment lyme diseaseScientific Reports · 2026-02-25Reported Safety Practices of Publicly Advertised Psychedelic Retreats.JAMA network open · 2026-01-02Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy: A Systematic Review and Meta-Analysis.JAMA network open · 2026-01-02The Effect of Magic Mushroom (Psilocybe azurescens) on Social Interaction, Anxiety- and Depressive-Like Behaviors in Male Rats; the Role of Neuroinflammation, Oxidative Stress, and Neurotrophic Factors.Journal of neuroscience research · 2026-01-01Active Constituents of Psilocybin Mushroom Edibles.JAMA network open · 2025-09-02An overview of psilocybin, LSD, MDMA, and ketamine in revitalizing psychedelic-assisted therapy: Insights, limitations and future directions.Progress in neuro-psychopharmacology & biological psychiatry · 2025-08-30Control Group Outcomes in Trials of Psilocybin, SSRIs, or Esketamine for Depression: A Meta-Analysis.JAMA network open · 2025-07-01Psilocybin Dispensaries and Online Health Claims in Canada.JAMA network open · 2025-04-01Psilocybin Dispensaries and Advertising-Buyer Beware.JAMA network open · 2025-04-01Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 Pandemic: A Randomized Clinical Trial.JAMA network open · 2024-12-02Psilocybin Fungi Unveiled: Morphological Characteristics and Pharmacological PotentialsInternational Journal for Research in Applied Science and Engineering Technology · 2024-11-17Acute Adverse Effects of Therapeutic Doses of Psilocybin: A Systematic Review and Meta-Analysis.JAMA network open · 2024-04-01Prefrontal Electrophysiological Biomarkers and Mechanism-Based Drug Effects in a Rat Model of Alcohol AddictionResearch Square · 2024-02-22Referee report. For: Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol [version 1; peer review: 1 approved with reservations]Faculty of 1000 Research Ltd · 2024-01-01Psychedelic Targeting of Metabotropic Glutamate Receptor 2 and Its Implications for the Treatment of Alcoholism.Cells · 2023-03-22Canalization and plasticity in psychopathology.Neuropharmacology · 2023-03-15Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex.NeuroImage · 2022-08-01Exposure-Response Analysis to Assess the Concentration-QTc Relationship of Psilocybin/PsilocinClinical Pharmacology in Drug Development · 2021-01-01Serotonergic Psychoactive Compounds as a Treatment for Addiction, Anxiety, and Depression: Their Efficacy and LegalityFurman University Scholar Exchange (Furman University) · 2019-01-01Activity and Enzyme Kinetics of Human UDP-Glucuronosyltransferases: Studies of Psilocin Glucuronidation and the Effects of Albumin on the Enzyme Kinetic MechanismTyöväentutkimus Vuosikirja · 2013-03-06Glucuronidation of Psilocin and 4-Hydroxyindole by the Human UDP-GlucuronosyltransferasesDrug Metabolism and Disposition · 2010-03-01[Intoxications by hallucinogenic mushrooms].Annales de medecine interne · 2000-10-01

Author directory

Robin Carhart-Harris178 publicationsDavid Nutt122 publicationsDavid Erritzøe85 publicationsFranz X. Vollenweider85 publicationsRoland R. Griffiths84 publicationsMatthew W. Johnson71 publicationsKatrin H. Preller64 publicationsFrederick S. Barrett61 publicationsGitte M. Knudsen58 publicationsLeor Roseman55 publicationsJames Rucker49 publicationsAlbert Garcia-Romeu46 publicationsTomáš Páleníček45 publicationsPatrick M. Fisher44 publicationsSandeep M. Nayak43 publicationsDea Siggaard Stenbæk42 publicationsJoshua D. Rosenblat42 publicationsKim P. C. Kuypers41 publicationsNatasha L. Mason38 publicationsPeter S. Hendricks38 publicationsAlan K. Davis36 publicationsDavid Bryce Yaden35 publicationsMatthias E. Liechti34 publicationsChristopher Timmermann33 publicationsJohns Hopkins University33 publicationsMuhammad Ishrat Husain33 publicationsBrice Ozenne32 publicationsGuy M. Goodwin30 publicationsHannes Kettner30 publicationsRoger S. McIntyre30 publicationsDirk Hoffmeister29 publicationsJohannes G. Ramaekers29 publicationsMichael P. Bogenschutz29 publicationsStephen Ross29 publicationsErich Seifritz27 publicationsRobert B. Kargbo27 publicationsBrian Anderson26 publicationsXiaohui Wang26 publicationsCharles D. Nichols25 publicationsDrummond E-Wen McCulloch25 publicationsJavier González-Maeso25 publicationsMartin Korsbak Madsen25 publicationsRichard J. Zeifman25 publicationsAllan H. Young24 publicationsGabrielle Agin-Liebes24 publicationsMartin Kuchař24 publicationsMorten L. Kringelbach24 publicationsNathan D. Sepeda24 publicationsPaul Liknaitzky24 publicationsFriederike Holze23 publicationsNatalie Gukasyan23 publicationsRAFAEL GUIMARÃES DOS SANTOS23 publicationsGustavo Deco22 publicationsScott Aaronson22 publicationsAdam L. Halberstadt21 publicationsBrian S. Barnett21 publicationsBruna Giribaldi21 publicationsJacob S. Aday21 publicationsJaime E. C. Hallak21 publicationsManoj Doss21 publicationsOlivia Carter21 publicationsOtto Simonsson21 publicationsBenjamin Kelmendi20 publicationsJiřı́ Horáček20 publicationsMichael Kometer20 publicationsAlex Kwan19 publicationsBernard Lerer19 publicationsMatthew B. Wall19 publicationsRoland A. Fischer19 publicationsRotem Petranker19 publicationsCharles L. Raison18 publicationsDavid E. Nichols18 publicationsEnzo Tagliazucchi18 publicationsFelix Müller18 publicationsFilip Tylš18 publicationsMendel Kaelen18 publicationsRobert A. Schoevers18 publicationsAlexander M. Sherwood17 publicationsAmanda Feilding17 publicationsChristopher S. Stauffer17 publicationsDavid J. Hellerstein17 publicationsFernando Rosas17 publicationsJason Luoma17 publicationsJeffrey Guss17 publicationsMilan Scheidegger17 publicationsTomislav Majić17 publicationsWilliam A. Richards17 publicationsClaire J. Foldi16 publicationsEmmanuelle A. D. Schindler16 publicationsGeyer MA16 publicationsKevin F. Boehnke16 publicationsLea J. Mertens16 publicationsMalievskaia E16 publicationsManish Agrawal16 publicationsNadav Liam Modlin16 publicationsSophia Armand16 publicationsYale University16 publicationsAnna M. Becker15 publicationsCharles S. Grob15 publicationsFelix Hasler15 publicationsGerhard Gründer15 publicationsJennifer Jones15 publicationsJoshua S. Siegel15 publicationsKelly JR15 publicationsLindsey Marwood15 publicationsSuresh Muthukumaraswamy15 publicationsTzuri Lifschytz15 publicationsUniversity Hospital15 publicationsBoadie W. Dunlop14 publicationsBrandon Weiss14 publicationsChristopher Pittenger14 publicationsDanica E. Johnson14 publicationsFederico Seragnoli14 publicationsGregor Hasler14 publicationsHenrik Jungaberle14 publicationsJanis Fricke14 publicationsJeng-Yu Tsai14 publicationsJochen Gartz14 publicationsJosé Carlos Bouso14 publicationsMeg J Spriggs14 publications